MedComm

MedComm is a peer‐reviewed, online OA journal that publishes the pioneer works of medicine on the basis of novelty, timeliness and significance on human health.

[MedComm @MedComm_MC]

🎉Congratulations！
In the recently released JCR Impact Factor 2025, MedComm-Oncology maintained an IF of 8.5, placing it in the Q1 category for Oncology, ranking 40/333. Welcome to submit your next manuscripts to MedComm-Oncology!
#JCR2026 #TrustedJournals #ImpactFactor

[MedComm @MedComm_MC]

🧬 #OriginalArticle in #MedComm_Future_Medicine
🔬 GABAergic TH2 Amacrine Cells Participate in Spontaneous Wave Activity in the Developing Retina
🔗 https://t.co/gSbihWVvKQ

#Retina #AmacrineCells #GABAergic #RetinalDevelopment #Neuroscience

@EyeResearchers @oaklandu

[MedComm @MedComm_MC]

🧬 #Review in #MedComm_Biomaterials_and_Applications
🔬 Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy
🔗 https://t.co/2SF7hoxaoh

#Biomaterials #Macrophages #Immunotherapy #TissueRegeneration #CancerImmunotherapy #Bioengineering

[MedComm @MedComm_MC]

🧬 #Review in #MedComm
🔬 Mitochondria as the Hub of Apoptosis: A Comprehensive Insight From Mitochondria to Interactions With Other Organelles
🔗 https://t.co/ic8S0awUEh
#Mitochondria #Apoptosis #CellDeath #CancerTherapy #OrganelleInteraction #PrecisionMedicine

[MedComm @MedComm_MC]

🧬 #Review in #MedComm
🧠 Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
🔗 https://t.co/pmNKgdaR8L
#NeurodegenerativeDiseases #CellDeath #Neuroscience #TherapeuticTargets

[MedComm @MedComm_MC]

The 13th West China International Forum for Emergency Medicine (#WCIFEM2026) concluded in Chengdu, China, focusing on value-based emergency care and the smart transformation of emergency medicine.
Read more👇#EmergencyMedicine #CriticalCare #ValueBasedCare #WestChinaHospital

[MedComm @MedComm_MC]

🧬 #Review in #MedComm-Future Medicine
🔬 Advances in Research on the Anti-Tuberculosis Effects of Active Components in Chinese Herbal Medicine
🔗 https://t.co/QbnvvmMObw
#Tuberculosis #ChineseHerbalMedicine #DrugResistance #GuangdongMedicalUniversity

[MedComm @MedComm_MC]

🧬 #Review in #MedComm-Biomaterials and Applications
🔬 Dual-Drug-Loaded Liposomes: Design Strategies, Mechanistic Insights, and Therapeutic Applications in Cancer
🔗 https://t.co/loDjT7uHRF
@bhupro #Liposomes #DrugDelivery #Nanomedicine #CancerTherapy

[MedComm @MedComm_MC]

🧬 #Review in #MedCommOncology
🔬 Nanoparticle-Mediated Therapy for Glioma: Advances and Prospects
🔗 https://t.co/RpC8uKbnjQ
@SCUCN #Glioma #Nanoparticle #DrugDelivery #WestChinaHospital #PrecisionOncology

[MedComm @MedComm_MC]

🧬 #Review in #MedComm
🔬 Lymphatic Endothelial Cells in Health and Disease
🔗 https://t.co/qTgDW2qDoz
#LymphaticEndothelialCells #TissueHomeostasis #PrecisionMedicine #HUST

[MedComm @MedComm_MC]

🧬 #Review in #MedCommOncology
🔬 Prostate Cancer Development, Progression, and Therapy
🔗 https://t.co/bAj12knjAa

@ZhejiangUniv #ProstateCancer #CRPC #PrecisionOncology

[MedComm @MedComm_MC]

🧬 #Review in #MedComm

🔬 Pathways of Protein Secretion in Prokaryotes and Eukaryotes: Molecular Mechanisms, Biological Functions, and Therapeutic Opportunities
🔗 https://t.co/xcd7EVZ91x

#ProteinSecretion #CellBiology #OpenAccess

[MedComm @MedComm_MC]

#Review in #MedComm #Nonclassical #MHC1 Molecules: Emerging Therapeutic Targets in Next-Generation #Immunotherapy
https://t.co/TcLsxiufHW
Nonclassical MHC-I molecules (HLA-E, HLA-F, HLA-G, CD1, MR1) offer next-generation targets for immunotherapy.
#HLA #AntigenPresentation

[MedComm @MedComm_MC]

🎉Congratulations！
In the recently released JCR Impact Factor 2025, MedComm maintained an IF of 14.1, placing it in the Q1 category for Medicine, Research & Experimental, ranking 11/191. Welcome to submit your next manuscripts to MedComm!#JCR2026 #TrustedJournals #ImpactFactor

[MedComm @MedComm_MC]

#Letter in #MedComm_Oncology
A #Retrospective #Cohort Study: Association of Helicobacter Pylori With #Radiotherapy Efficacy in Metastatic Colorectal Cancer and #Recurrence Risk Following Preoperative Therapy https://t.co/svaMdTg8xR

#HelicobacterPylori #Hp #ColorectalCancer

[MedComm @MedComm_MC]

#Article in #MedComm_Oncology
Tumor-Resident Mast Cells (#MCs) Facilitated #BreastCancer Progression via Activating Type I #Interferon #Pathway https://t.co/ilxrZck2fy

@ZJU_China #CSC #interferonβ #MAPK #ERK #IFNAR1 #STAT1

[MedComm @MedComm_MC]

#Article in #MedComm_Biomaterials_and_Applications
The Use of #FN-Silk Networks as Extracellular Matrix-Mimicking Support for 3D In Vitro Breast Cancer Models Improved the Model's Reproducibility in Drug Sensitivity https://t.co/QFV8yi3SeY

@KTHuniversity #3Dmodel #BreastCancer

[MedComm @MedComm_MC]

#Review in #MedComm_Oncology
The Dual Role of #Autophagy in #Cancer: Mechanisms and Therapeutic Strategies https://t.co/rDlE85NPQR

It expands the functional scope of autophagy, and provides a solid foundation for preventive and #therapeutic strategies against cancer. @UM_1981

[MedComm @MedComm_MC]

#Highlight in #MedComm_Biomaterials_and_Applications
#Biohybrids for Health Care: Towards Next-Generation #Biomaterials #Application https://t.co/ce0CW8nSuQ

The highlighted article in @ACSChemRev : https://t.co/YWbnQAmR6N

@SCUCN

[MedComm @MedComm_MC]

#Highlight in #MedComm_Oncology
The #Acidic Conductor: How Tumor #Acidosis Orchestrates Metabolic Adaptation https://t.co/umUQMqyKXG

The highlighted article in @ScienceMagazine : https://t.co/ZVQKulIiSp

@johanneszuber @WilhelmPalm